Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting

被引：0
|
作者：
Fautrel, Bruno [1 ,2 ]
Assing, Maryse [3 ]
Mammar, Nadir [3 ]
Brault, Yves [3 ]
Marotte, Hubert [4 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France
[3] Pfizer, Paris, France
[4] INSERM 1059, St Etienne, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1426
引用
收藏
页码：2810 / 2812
页数：3
相关论文
共 50 条
  • [41] Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry
    Nabi, H.
    Glintborg, B.
    Loft, A. G.
    Hendricks, O.
    Pedersen, J. K.
    Just, S. A.
    Ahmed, R.
    Danebod, K.
    Munk, H. L.
    Colic, A.
    Linauskas, A.
    Jensen, D. V.
    Christensen, L. B.
    Manilo, N.
    Lomborg, N.
    Kristensen, S.
    Mehnert, F.
    Krogh, N. S.
    Hetland, M. L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 14 - 15
  • [42] A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) FOR SUBCUTANEOUS ADMINISTRATION: 1-YEAR RESULTS FROM A PART 1 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Yoo, DaeHyun
    Jaworski, Janusz
    Matyska-Piekarska, Ewa
    Smiyan, Svitlana
    Ivanova, Delina
    Zielinska, Agnieszka
    Raussi, Eve-Kai
    Batalov, Anastas
    Lee, Sangjoon
    Suh, Jeehye
    Han, Noori
    Westhovens, Rene
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 733 - 733
  • [43] STATISTICAL EVALUTION OF JOINT DAMAGE PRGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH INFLIXIMAB OR BIOSIMILAR INFLIXIMAB (CT-P13) ANTI-TNF THERAPY: A ROLE OF SENSITIVITY ANALYSIS FOR MISSING DATA EVALUATING SIMILARITY
    Lee, S. J.
    Yoo, D. H.
    Park, W.
    Mueller-Ladner, U.
    Pyo, T. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 667 - 667
  • [44] A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY
    Yoo, D. H.
    Racewicz, A.
    Brzezicki, J.
    Yatsyshyn, R.
    Arteaga, E. Tobias
    Baranauskaite, A.
    Abud-Mendoza, C.
    Navarra, S.
    Eullaran, R.
    Kadinov, V.
    Sariego, I. Goecke
    Byrne, P.
    Park, W.
    Lee, S. J.
    Kim, H. U.
    Mueller-Ladner, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 73 - 73
  • [45] The comparative impact of TNF-blocking agents on health related quality of life in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis:: 6-month results from a longitudinal, observational study.
    Heiberg, Marte S.
    Kaufmann, Cecilie
    Nordvåg, Bjorn-Yngvar
    Rodevand, Erik
    Mikkelsen, Knut
    Mowinckel, Petter
    Kvien, Tore K.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S721 - S721
  • [46] Anti-TNF α antibodies in patients with inflammatory bowel disease naive to anti-TNF therapy treated with biosimilar infliximab (CT-P13): a prospective single-centre real-life study
    Filip, R.
    Pekala, A.
    Jarmakiewicz-Czaja, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S396 - S397
  • [47] Early vs delayed treatment in recent onset rheumatoid arthritis patients: Results from a two year controlled follow-up study in an early arthritis clinic.
    Lard, LR
    Visser, H
    Speyer, I
    van der Horst-Bruinsma, IE
    Zwinderman, AH
    Breedveld, FC
    Hazes, JMW
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S154 - S154
  • [48] HIGH REMISSION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS UNDER A TREAT TO TARGET STRATEGY AND A COMPREHENSIVE DISEASE-MANAGEMENT MODEL. FIVE YEAR FOLLOW-UP RESULTS FROM A REAL-LIFE SETTING
    Santos-Moreno, Pedro
    Cabrera, Michael
    Buitrago-Garcia, Diana
    Cardozo, Eva
    Ramirez, Ivania
    Gomez, Danny
    Castillo, Edwin
    Farietta, Sandra
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1664 - 1664
  • [49] Remission in early rheumatoid arthritis treated with conventional DMARDs. Results of a two-year follow-up study of El Ayachi Moroccan cohort
    Benbouazza, Karima
    Rkain, Hanan
    Benchekroun, Bahia
    Amine, Bouchra
    Bzami, Fatiha
    Benbrahim, Leila
    Atouf, Ouafa
    Essakalli, Malika
    Abouqal, Redouane
    Dougados, Maxime
    Hajjaj-Hassouni, Najia
    JOINT BONE SPINE, 2012, 79 (01) : 43 - 46
  • [50] A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study
    Dae Hyun Yoo
    Artur Racewicz
    Jan Brzezicki
    Roman Yatsyshyn
    Edgardo Tobias Arteaga
    Asta Baranauskaite
    Carlos Abud-Mendoza
    Sandra Navarra
    Vladimir Kadinov
    Irmgadt Goecke Sariego
    Seung Suh Hong
    Sung Young Lee
    Won Park
    Arthritis Research & Therapy, 18
12345